MLAB · Mesa Laboratories Inc /Co/ · Executive Compensation
$125.90
+2.60 (+2.10%)
At close · Oct 20
View the 10-K filed Jun 3, 2026
Return incl. dividend (before tax)
Customer concentration
— top customer 20% of revenue
One customer — 20% of revenue (fiscal 2026)
“In our Clinical Genomics division, a significant portion of revenues is generated from ongoing purchases by a relatively small number of established customers, with a single customer accounting for approximately 20% of the division's revenues in fiscal 2026.”
Market Cap
$690.00M
Shares
5.60M
Volume · Oct 20
77.23K
Avg daily vol (3M)
133.1K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2026
| Executive | Role | Total |
|---|---|---|
| Gary Owens | Former CEO and President | $6,643,208 |
| John Sakys | VP and Chief Financial Officer | $2,471,543 |
| Brian Archbold | SVP of Operations and Continuous Improvement | $2,182,518 |
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Gary Owens | CEO and President | $6,599,891 |
| John Sakys | VP and Chief Financial Officer | $2,424,110 |
| Brian Archbold | SVP of Operations and Continuous Improvement | $2,134,556 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Gary Owens | CEO and President | $5,435,566 |
| John Sakys | VP and Chief Financial Officer | $1,943,292 |
| Brian Archbold | SVP of Operations and Continuous Improvement | $1,622,620 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Gary Owens | CEO and President | $5,190,371 |
| John Sakys | VP and Chief Financial Officer | $1,907,475 |
| Brian Archbold | SVP of Operations and Continuous Improvement | $1,460,527 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Gary Owens | CEO and President | $18,076,981 |
| John Sakys | VP and Chief Financial Officer | $1,893,116 |
| Greg DiNoia | Former SVP Commercial | $1,263,057 |
| Brian Archbold | SVP of Operations and Continuous Improvement | $1,200,506 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Gary Owens | CEO and President | $2,557,718 |
| John Sakys | VP and Chief Financial Officer | $1,109,687 |
| Greg DiNoia | Former SVP Commercial | $897,087 |
| Brian Archbold | SVP of Operations and Continuous Improvement | $775,630 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Gary Owens | CEO and President | $3,485,969 |
| John Sakys | Chief Financial Officer | $1,128,605 |
| Greg DiNoia | SVP Commercial | $898,969 |
| Brian Archbold | SVP of Operations and Continuous Improvement | $700,877 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Gary Owens | CEO and President | $3,270,589 |
| John Sakys | Chief Financial Officer | $1,027,193 |
| Greg DiNoia | SVP of Commercial Operations | $866,635 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Gary Owens | member of the Company's board of directors | Resigned | 2026-03-23 |
| Gary Owens | President and Chief Executive Officer | Resigned | 2026-03-23 |
| Siddhartha Kadia | Board of Directors | Appointed | 2026-03-09 |
| Siddhartha Kadia | President and Chief Executive Officer | Appointed | 2026-03-09 |
| Dr. Siddhartha Kadia | member of the Board | Appointed | 2026-03-09 |
| Dr. Siddhartha Kadia | President and Chief Executive Officer | Appointed | 2026-03-09 |
| Shiraz Ladiwala | Audit Committee | Resigned | 2024-01-08 |
Leadership
- Dr. Siddhartha Kadia CEO, Board Member
- Siddhartha Kadia CEO, Board Member
- John Sakys CFO
- Gary M. Owens Board Member
- Jennifer S. Alltoft Board Member
- John J. Sullivan Board Member
- Mark C. Capone Board Member
- R. Tony Tripeny Board Member
- Shannon Hall Board Member
- Shannon M. Hall Board Member
- Shiraz S. Ladiwala Board Member
- Tony Tripeny Board Member
Key facts
CIK
724004
CUSIP
59064R109
13F (30d)
16 filings
16 filers
Visit website
Investor relations